###begin article-title 0
Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers
###end article-title 0
###begin p 1
Recommended by Nima Rezaei
###end p 1
###begin p 2
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 491 492 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 502 503 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 503 504 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 518 519 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 519 520 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 520 521 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 683 684 683 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 684 685 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 685 686 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 775 776 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 0 7 <span type="species:ncbi:4097">Tobacco</span>
Tobacco smoking has been considered the most important risk factor for chronic obstructive pulmonary disease (COPD) development. However, not all smokers develop COPD and other environmental and genetic susceptibility factors underlie disease pathogenesis. Recent studies have indicated that the impairment of TLR signaling might play a crucial role in the development of emphysema. For this purpose we investigated the prevalence and any possible associations of common TLR polymorphisms (TLR2-R753Q, TLR4-D299G, and TLR4-T399I) in a group of 240 heavy smokers (>20 pack years), without overt atherosclerosis disease, of whom 136 had developed COPD and 104 had not. The presence of TLR4-T399I polymorphism was associated with a 2.4-fold increased risk for COPD development (P = .044), but not with disease stage or frequency of exacerbations. Considering that infections contribute to COPD and emphysema pathogenesis, our findings possibly indicate that dysfunctional polymorphisms of innate immune genes can affect the development of COPD in smokers. Although this finding warrants further investigation, it highlights the importance of impaired innate immunity towards COPD development.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 591 592 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 593 594 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 728 729 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 731 732 731 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 240 247 <span type="species:ncbi:4097">Tobacco</span>
Emerging evidence suggests that immune cells accumulate in bronchial biopsy specimens in patients with chronic obstructive pulmonary disease (COPD) [1, 2], questioning in this way whether the lung destruction in COPD is immune cell driven. Tobacco smoking has been identified as the most important risk factor of the disease [3, 4], interfering with the innate host defense system by damaging cells through the attack of oxidants, increasing mucus production, reducing mucociliary clearance, and disrupting the epithelial barrier [1]. Considering that less than 20% of smokers develop COPD [3-5], it has been suggested that additional susceptibility factors might be implicated in lung obstruction and emphysema development [2, 6, 7].
###end p 4
###begin p 5
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 599 600 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 637 638 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 638 639 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</italic>
###xml 639 640 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 641 646 641 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> &#8722; /&#8722;</sup>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 247 255 <span type="species:ncbi:9606">patients</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
It is well accepted nowadays that factors favoring infections contribute to COPD development, since air pollution, latent adenoviral infections, and childhood respiratory infections have been implicated in disease pathogenesis, in a proportion of patients [3, 4, 8]. In this context, recent studies have demonstrated that impaired signaling of innate immunity receptors may contribute to COPD and emphysema pathogenesis [9-11]. Amongst these receptors, Toll-like receptor (TLR) 4 seems to play a pivotal role in lung homeostasis by contributing to the defense of endothelial cells against oxidants [9, 10]. Moreover, TLR4-knockout mice (Tlr4 - /- mice) spontaneously develop emphysema, associated with an oxidant/antioxidant imbalance, due to increased Nox3 gene expression and elastin degradation [11]. The impairment of TLR signaling in vivo becomes evident through the presence of single nucleotide polymorphisms (SNPs) that have been associated with receptor hypo-responsiveness and susceptibility to bacterial, fungal, and viral infections (reviewed by Schroder and Schumann) [12].
###end p 5
###begin p 6
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 452 455 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 470 474 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 498 502 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
Amongst TLRs, TLR-4 recognizes lipopolysaccharides of Gram (-) bacteria, while TLR-2 recognizes endogenous inflammatory mediators in addition to microbial products like lipotheicoic acid of Gram (+) bacteria [12], namely, the pathogens that play a crucial role, at least, in COPD phenotype (frequency and severity of exacerbation attacks) [13]. Thus, based on the abovementioned data, the present study was designed to analyze the prevalence of common TLR SNPs, namely, TLR2-R753Q, TLR4-D299G, and TLR4-T399I, in a cohort of smokers with and without COPD, in order to demonstrate their possible contribution to disease pathogenesis and phenotype.
###end p 6
###begin title 7
2. Materials and Methods
###end title 7
###begin title 8
2.1. Study Population
###end title 8
###begin p 9
###xml 40 48 <span type="species:ncbi:9606">patients</span>
One hundred and thirty-four (134) Greek patients with COPD (male/female: 133/1, mean age: 69.4 years, range: 39-88) and 106 Greek smokers without the disease (male/female: 102/4, mean age: 63 years, range: 40-84), who were randomly selected between October 2005 and October 2008, were enrolled in the study. Individuals with a history of severe cardiovascular comorbidities (including coronary artery disease or stroke) were excluded from the study. Additionally, individuals with coexisting asthma or atopy, autoimmune diseases, and cancer were not enrolled in the study.
###end p 9
###begin p 10
###xml 4 16 <span type="species:ncbi:9606">participants</span>
###xml 188 200 <span type="species:ncbi:9606">participants</span>
All participants had a smoking history of more than 20 pack years (pys) and were current smokers or ex-smokers, the latter being defined as having quit smoking for more than one year. All participants, including normal controls, were submitted to physical examination and spirometry and filled in a detailed questionnaire, including the presence of respiratory symptoms (e.g., cough, sputum, and dyspnoea). Dyspnoea severity was estimated according to the Medical Research Council (MRC) scale.
###end p 10
###begin p 11
###xml 116 117 116 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 642 644 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 795 797 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1179 1186 1171 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 800 808 <span type="species:ncbi:9606">Patients</span>
###xml 1037 1044 <span type="species:ncbi:9606">patient</span>
###xml 1094 1102 <span type="species:ncbi:9606">patients</span>
COPD diagnosis was based on spirometric data showing airway obstruction (forced expiratory volume in one second [FEV1]/forced vital capacity [FVC] < 70%) in individuals with a smoking habit >20 pys, according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2007 guidelines [13]. Classification of COPD severity was based on postbronchodilator FEV1, according to GOLD guidelines (Stage I-mild COPD FEV1 >/= 80.0% predicted; Stage II-moderate COPD 50.0% </= FEV1 < 80.0% predicted; Stage III-severe COPD 30.0% </= FEV1 < 50.0%; Stage IV-very severe COPD 30.0% </= FEV1, or FEV1 < 50.0% predicted with respiratory failure) [13]. Spirometry was carried out with a dry spirometer (Koko Legend, Ferraris Louisville, CO, USA) according to the American Thoracic Society guidelines [14]. Patients exhibiting three or more COPD exacerbations, or two or more exacerbations including one hospitalization due to COPD in the previous year, were considered frequent exacerbators. The evaluation of exacerbation status was based on patient records and was available in 123 out of 134 COPD patients. Clinical and demographic data of the enrolled individuals are presented in Table 1.
###end p 11
###begin p 12
All subjects provided written informed consent. The study was conducted in accordance with the principles of Helsinki declaration and was approved by the Institutional Review Board of the University Hospital of Larissa, Greece.
###end p 12
###begin title 13
2.2. Molecular Techniques
###end title 13
###begin p 14
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 685 689 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
Genomic DNA was extracted from peripheral blood using the QIAamp DNA Blood Mini Kit (Qiagen), according to manufacturer's instructions. The detection of the TLR4-D299G and TLR4-T399I polymorphisms was performed by allele-specific PCR followed by restriction fragment length polymorphism (PCR-RFLP) analysis, as described previously [15, 16]. In brief, the forward primers, in both reactions, were modified at the 5' end, creating restriction enzyme recognition sites (NcoI for the TLR4-D299G polymorphism and HinfI for the TLR4-T399I), so that if a polymorphism is present, then PCR-RFLP analysis will create digestion fragments, visible on agarose gels [15, 16]. The detection of the TLR2-R753Q polymorphism was also performed by PCR-RFLP, since the presence of polymorphism results in the alteration of DNA sequencing, allowing digestion by SfcI [17]. Primers used for the PCR amplification of TLR2 gene were previously described by Ogus et al. [18]. All PCR and digestion procedures were carried out in the PCR-engine apparatus PTC-200, MJ-Research (Watertown, Massachusetts), while the PCR and digestion products were analyzed in 2% TBE agarose gels.
###end p 14
###begin p 15
###xml 102 105 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
For the confirmation of PCR-RFLP results, randomly chosen PCR products, positive and negative for the TLR polymorphisms, were purified by Qiagen PCR Purification System (Qiagen, UK) and sequenced using an ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, CA) and a Big Dye Terminator DNA sequencing kit (Applied Biosystems).
###end p 15
###begin title 16
2.3. Statistical Analysis
###end title 16
###begin p 17
###xml 12 15 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;</italic>
###xml 224 227 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 439 440 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 591 592 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Chi-square (chi2) test along with Yates' correction was used to compare the allele and genotype frequencies between disease and control groups. Fisher's exact test was used when appropriate. The association between COPD and TLR polymorphisms, and the other categorical clinicolaboratory variables of interest, was tested using a univariate logistic regression model. Continuous variables were compared using the nonparametric Mann-Whitney U-test. An association was expressed as odds ratio (OR) with the corresponding 95% confidence interval (CI). A variable was considered significant when P< .05. The above analyses were performed using SPSS (version 10.0, Chicago, IL, USA). At the end, the deviations from Hardy-Weinberg equilibrium were evaluated using the freely available software Arlequin 3.11 ().
###end p 17
###begin title 18
3. Results
###end title 18
###begin title 19
###xml 40 48 <span type="species:ncbi:9606">Patients</span>
3.1. TLR Polymorphisms Analysis in COPD Patients and Normal Smokers
###end title 19
###begin p 20
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 76 84 76 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 319 322 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 479 480 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 550 554 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 640 641 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 685 689 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 779 780 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 858 862 858 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 954 955 954 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1024 1025 1024 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1042 1043 1042 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1143 1150 1143 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 427 435 <span type="species:ncbi:9606">patients</span>
###xml 736 744 <span type="species:ncbi:9606">patients</span>
Examples of the detection of TLR polymorphisms by PCR-RFLP are presented in Figure 1. Direct sequencing of 32 randomly chosen samples (5 heterozygotes for both TLR4 polymorphisms, 2 heterozygotes for the TLR2-R753Q, and 25 wild-type) confirmed the results of PCR-RFLP analysis. No one individual was homozygous for any TLR polymorphism. The allele and genotype frequencies of the TLR4-T399I SNP were significantly increased in patients with COPD when compared to normal smokers (P = .046 and P = .039, resp.). Moreover, an increased frequency of the TLR4-D299G allele in COPD was also observed but failed to reach statistical significance (P = .061). Considering the prevalence of the TLR2-R753Q, no significant difference between COPD patients and healthy smokers was observed (P = .117). Logistic regression analysis revealed that individuals carrying the TLR4-T399I polymorphism displayed a 2.4-fold increased risk to develop COPD (95% CI: 1.02-5.64, P = .044). Other variables associated with COPD development were age (P< .001) and pys (P< .001). Considering the impact of the other polymorphisms, no significant difference was observed (Table 2).
###end p 20
###begin p 21
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 168 169 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
TLR4-T399I polymorphism was strongly associated with the value of FEV1/FVC ratio (P = .032) but not with disease stage and the frequency of exacerbations (P = .130 and P = .562, resp.). On the other hand, no significant correlation of the TLR2-R753Q and TLR4-D299G polymorphisms was observed with the evaluated parameters.
###end p 21
###begin p 22
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Moreover, positive strong correlations of COPD stage with pys (P< .001) and the frequency of exacerbations (P< .001) were found. Finally, the exacerbations of COPD were observed more frequently among heavy smokers (P = .015).
###end p 22
###begin title 23
3.2. The Hardy-Weinberg Principle among TLR SNPs
###end title 23
###begin p 24
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 344 345 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 357 358 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
###xml 375 383 <span type="species:ncbi:9606">patients</span>
The analysis suggests that both of the TLR4 gene polymorphisms obey Hardy-Weinberg principle in the group of COPD patients (P = .616 and P = .585, for the D299G and T399I SNPs, resp.) and normal smokers (P = .064 and P = .922, for the D299G and T399I SNPs, resp.). Moreover, TLR2-R753Q SNP shares the same deviant behavior in both populations (P = .976 and P = .940 for COPD patients and normal smokers, resp.).
###end p 24
###begin p 25
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 167 175 <span type="species:ncbi:9606">patients</span>
To this end, we confirmed that the G allele of TLR4-D299G SNP has a high level of linkage disequilibrium with the allele C of TLR4-T399I SNP (P<; .001), for both COPD patients and normal smokers, as reported previously [19].
###end p 25
###begin title 26
4. Discussion
###end title 26
###begin p 27
###xml 106 109 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
To the best of our knowledge, this is the first report examining a possible association of several common TLR polymorphisms with COPD development and severity in smokers. Clear evidence is presented for a novel association between TLR4-T399I polymorphism and susceptibility to COPD in Greek smokers, in view of the higher frequency of TLR4-399I allele in smokers with COPD compared to that of healthy ones.
###end p 27
###begin p 28
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1114 1116 1114 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 697 705 <span type="species:ncbi:9606">patients</span>
We should underscore that the sample size in our study was relatively small, and thus, the power of detecting significant results was limited (almost 20%). However, candidate-gene association studies have the tendency to lack the power to detect a statistically significant association. For example, in order to achieve a power >80% to identify a modest genetic effect (odds ratio 1.2) of a polymorphism present in 10% of individuals, a sample size of 10,000 subjects or more would be needed [20]. Therefore, the sample sizes required to predict association have to be far beyond what is currently available and no single institution or entity alone will be able to provide a reasonable number of patients. However, a future meta-analysis of multiple studies clearly has a role in offering an analysis with the potential for higher power [21]. Future collaborative studies may allow the pooling of data, providing more power to detect significant associations. Furthermore, consortia performing gene-candidate or genome wide associations studies will be able to replicate the validity of the present findings [21, 22].
###end p 28
###begin p 29
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4.</italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 508 521 508 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. influenzae</italic>
###xml 526 541 526 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. catarrhalis </italic>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 941 942 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 944 945 944 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 946 948 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 383 391 <span type="species:ncbi:9606">patients</span>
###xml 508 521 <span type="species:ncbi:727">H. influenzae</span>
###xml 526 540 <span type="species:ncbi:480">M. catarrhalis</span>
The two TLR4 SNPs analyzed in this study (D229G and T399I) are located in the extracellular domain of the human TLR4. These result in impaired TLR4 signaling, since they have been associated with receptor hyporesponsiveness in alveolar macrophages and epithelial cells, and peripheral blood mononuclear cells [19]. It has been estimated that the tracheobronchial tree of stable COPD patients is colonized with bacteria and viruses in approximately 30% of cases, many of which are recognized by TLR4, such as H. influenzae and M. catarrhalis [23]. Thus, any TLR4 dysfunction, such as the presence of T399I polymorphism, might reduce the clearance of the abovementioned pathogens, contributing to COPD pathophysiology. This is in accordance with previous studies where an aberrant innate immune response, being demonstrated by alterations of lung cytokines, oxidant stress, and TLR4 signaling, has been associated with experimental emphysema [7, 9-11].
###end p 29
###begin p 30
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 950 954 950 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 301 309 <span type="species:ncbi:9606">patients</span>
###xml 780 788 <span type="species:ncbi:9606">patients</span>
###xml 797 805 <span type="species:ncbi:9606">patients</span>
###xml 1131 1139 <span type="species:ncbi:9606">patients</span>
Till now, only two groups have been examined previously, the possible association of the TLR4-D299G SNP with COPD development, with conflicting findings [24, 25]. Rohde et al., having included a proportion of nonsmokers in the analyzed COPD group, reported a decreased frequency of TLR4-D299G in COPD patients compared to normal controls [24]. However, the interpretation of these results warrants caution, since no smoking habit determination was performed for the control group. For the latter, we consider it to be a very important issue in the design of disease association studies. On the other hand, Sabroe et al. screened a population of 289 smokers and observed no association between TLR4-D299G polymorphism and lung function [25]. However, they avoided describing their patients as COPD patients, whilst no details about clinical symptoms defining COPD are given. On the other hand, our findings suggest that there is no association of the TLR2-R753Q polymorphism with either the onset or the course of COPD. This is in accordance with the recent work by Pabst et al., where a similar finding was observed analyzing COPD patients and controls, including a significant number of nonsmokers [26].
###end p 30
###begin p 31
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 369 376 369 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 780 784 780 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 862 866 862 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 918 922 918 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 983 985 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1080 1084 1080 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
Considering the presence of linkage disequilibrium for the two TLR4 polymorphisms, we would expect similar results for the TLR4-D299G SNP to those observed for the TLR4-T399I. However in our study, although the presence of TLR4-D299G polymorphism was associated with a 2-fold increased risk for COPD development, this difference did not reach statistical significance (Table 2). It is worth of note that initial in vitro studies indicated that the TLR4-D299G genotype might have a greater functional impact compared with that of the TLR4-T399I genotype [19]. However, this might not be the case in vivo, since recent gene association studies have shown that the abovementioned SNPs could affect disease development in a different way. For example, Kiechl et al. observed that the TLR4-D299G SNP has a more profound protective effect to atherosclerosis risk than TLR4-T399I [27], while Torok et al. described that only TLR4-T399I SNP affects the susceptibility to ulcerative colitis [28]. It is obvious that further studies using appropriate animal models could verify the role of TLR4-T399I polymorphism.
###end p 31
###begin p 32
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
To this end, the present study has two major distinguishing factors compared to previous ones. First was the analysis of the TLR4-T399I polymorphism and second was the fact that no individuals with overt coronary artery disease or stroke were enrolled, considering the possible contribution of TLR4 SNPs in atherosclerosis development [27].
###end p 32
###begin title 33
5. Conclusions
###end title 33
###begin p 34
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
A novel association between a functional polymorphism in TLR4 (T399I) and COPD is reported. Considering that infections contribute to COPD and emphysema pathogenesis, our findings possibly indicate that dysfunctional polymorphisms of innate immune genes can affect the development of COPD in smokers. Although this finding warrants further investigation, it highlights the importance of impaired innate immunity towards COPD development.
###end p 34
###begin title 35
Acknowledgments
###end title 35
###begin p 36
The authors wish to thank Dr. Vaios Karanikas for critical appraisal of the manuscript, Dr. Vassileios Papadopoulos for statistical advice, and the medical doctors Kalliopi Tanou, Andriana Papaioannou, Rita Tsaroucha, and Ioanna Verou for the performance of spirometries and blood sampling.
###end p 36
###begin article-title 37
The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research
###end article-title 37
###begin article-title 38
The nature of small-airway obstruction in chronic obstructive pulmonary disease
###end article-title 38
###begin article-title 39
COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity
###end article-title 39
###begin article-title 40
A reexamination of risk factors for ventilatory impairment
###end article-title 40
###begin article-title 41
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study
###end article-title 41
###begin article-title 42
Molecular genetics of chronic obstructive pulmonary disease
###end article-title 42
###begin article-title 43
Molecular pathogenesis of emphysema
###end article-title 43
###begin article-title 44
Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease
###end article-title 44
###begin article-title 45
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4
###end article-title 45
###begin article-title 46
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation
###end article-title 46
###begin article-title 47
Toll-like receptor 4 deficiency causes pulmonary emphysema
###end article-title 47
###begin article-title 48
Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease
###end article-title 48
###begin article-title 49
Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
###end article-title 49
###begin article-title 50
Standardization of spirometry: 1994 update
###end article-title 50
###begin article-title 51
Determination of the TLR4 genotype using allele-specific PCR
###end article-title 51
###begin article-title 52
###xml 20 34 20 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida krusei</italic>
###xml 39 55 39 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 20 34 <span type="species:ncbi:4909">Candida krusei</span>
###xml 39 55 <span type="species:ncbi:5478">Candida glabrata</span>
###xml 61 68 <span type="species:ncbi:9606">patient</span>
Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment
###end article-title 52
###begin article-title 53
High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR
###end article-title 53
###begin article-title 54
###xml 34 39 <span type="species:ncbi:9606">human</span>
The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease
###end article-title 54
###begin article-title 55
###xml 67 73 <span type="species:ncbi:9606">humans</span>
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
###end article-title 55
###begin article-title 56
Trends in meta-analysis of genetic association studies
###end article-title 56
###begin article-title 57
Genome-wide association studies: hypothesis-"free" or "engaged"?
###end article-title 57
###begin article-title 58
Replication validity of genetic association studies
###end article-title 58
###begin article-title 59
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush
###end article-title 59
###begin article-title 60
Association of the ASP299GLY TLR4 polymorphism with COPD
###end article-title 60
###begin article-title 61
Toll-like receptor (TLR) 4 polymorphisms and COPD
###end article-title 61
###begin article-title 62
Toll-like receptor 2 gene polymorphisms Arg677Trp and Arg753Gln in chronic obstructive pulmonary disease
###end article-title 62
###begin article-title 63
Toll-like receptor 4 polymorphisms and atherogenesis
###end article-title 63
###begin article-title 64
Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis
###end article-title 64
###begin p 65
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 452 456 452 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 634 638 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 736 740 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1019 1023 1019 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 1031 1035 1031 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1047 1051 1047 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 161 169 <span type="species:ncbi:9606">Patients</span>
(a) Representative digestions showing the TLR2-R753Q (A), TLR4-D299G (B), and TLR4-T399I (C) polymorphisms. M: 200 bp ladder molecular weight marker. Lanes 1-8: Patients with COPD; lane 9: negative PCR control. Samples without any polymorphism (1,3, 4,8) display undigested PCR products, 430 bp for the TLR2-R753Q, 249 bp for the TLR4-D299G, and 407 bp for the TLR4-T399I. Samples 5 and 7 are heterozygotes for the TLR2-R753Q polymorphism, whereas the TLR2-753Q allele contains a Sfc I restriction site resulting in 307 bp and 123 bp fragments. Samples 2 and 6 are double heterozygotes for both TLR4 polymorphisms. In particular, the TLR4-299G allele contains an NcoI restriction site resulting in 218 bp and 31 bp fragments, while the TLR4-399I allele contains a HinfI restriction site resulting in 375 bp and 28 bp fragments. The digestion products were analyzed on 2% of TBE agarose gels and the 28 bp and 31 bp fragments are not visible on agarose gels. (b) Representative sequencing analysis shows the presence of TLR2-R753Q, TLR4-D299G, and TLR4-T399I polymorphisms.
###end p 65
###begin p 66
Clinical and demographic data of study population.
###end p 66
###begin p 67
Abbreviations: COPD, chronic obstructive pulmonary disease; BMI, body mass index; Pys, pack years.
###end p 67
###begin p 68
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
Distribution of the TLR SNPs in smokers with and without COPD.
###end p 68
###begin p 69
Abbreviations: COPD, chronic obstructive pulmonary disease; CI, confidence intervals; wt, wild-type; het, heterozygous; hom, homozygous.
###end p 69

